Orbimed Advisors LLC Ionis Pharmaceuticals Inc Transaction History

Orbimed Advisors LLC

$4.24 Billion
Q3 2024

A detailed history of Orbimed Advisors LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Orbimed Advisors LLC holds 2,324,447 shares of IONS stock, worth $82.3 Million. This represents 2.19% of its overall portfolio holdings.

Number of Shares

2,324,447

Previous 2,372,333 2.02%

Holding current value

$82.3 Million

Previous $113 Million 17.64%

% of portfolio

2.19%

Previous 2.72%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$40.06 - $51.86 $1.92 Million - $2.48 Million	-47,886 Reduced 2.02%	2,324,447 $93.1 Million
Q2 2024 Aug 14, 2024	BUY	$36.45 - $47.7 $13.1 Million - $17.1 Million	359,300 Added 17.85%	2,372,333 $113 Million
Q1 2024 May 15, 2024	SELL	$42.03 - $53.55 $2.18 Million - $2.77 Million	-51,764 Reduced 2.51%	2,013,033 $87.3 Million
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $4.54 Million - $5.41 Million	-104,703 Reduced 4.83%	2,064,797 $104 Million
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $1.56 Million - $1.95 Million	45,000 Added 2.12%	2,169,500 $89 Million
Q1 2023 May 15, 2023	BUY	$33.58 - $41.2 $4.4 Million - $5.39 Million	130,900 Added 6.57%	2,124,500 $75.9 Million
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $45.5 Million - $57 Million	1,224,700 Added 159.28%	1,993,600 $75.3 Million
Q3 2022 Nov 14, 2022	BUY	$36.54 - $48.66 $11.5 Million - $15.4 Million	315,500 Added 69.59%	768,900 $34 Million
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $14.4 Million - $19.5 Million	453,400 New	453,400 $16.8 Million
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $4.45 Million - $6.78 Million	-106,900 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $5.76 Million - $6.98 Million	106,900 New	106,900 $6.46 Million

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.02B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account

Orbimed Advisors LLC Ionis Pharmaceuticals Inc Transaction History